MedTrace Logo

The Effectiveness of Oral Acyclovir in the Treatment of Molluscum Contagiosum in Children

NCT04476186 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2020-07-20

No results posted yet for this study

Summary

The investigators will study the effectiveness of acyclovir in the treatment of molluscum contagiosum in assiut university hospital - dermatological out patient clinic the treatment group will receive acyclovir 200 mg 5 times per day the controlled group will receive local KOH solution

Conditions

  • Molluscum Contagiosum

Interventions

DRUG

Acyclovir

oral syrp

DRUG

KOH 10 %

solution for local application

Sponsors & Collaborators

  • assistant professor Ghada M. Khafagy

    collaborator UNKNOWN

  • Dr. Marwa Diaaeldeen Abbass Hasan

    collaborator UNKNOWN

  • Prof. Dr. Emad Taha Abd-Elahim Ebiad

    collaborator UNKNOWN

  • Dalia Mahran

    lead OTHER

Principal Investigators

  • Ghada Mahmoud, Assist Prof · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-15
Primary Completion
2021-12-29
Completion
2021-12-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04476186 on ClinicalTrials.gov